Nuclear Imaging Agents Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

Nuclear Imaging Agents Market Report Overview

The nuclear imaging agents market size was $998 million in 2023. Factors such as technical advancements and applied research will drive the market growth at a CAGR of more than 2% from 2023 to 2033.

Nuclear imaging is a non-invasive medical technique that uses radioactive tracers (generally F-18 Fluorodeoxyglucose) to assess and diagnose bodily functions and diseases. The diseases include cancers, cardiac diseases, gastrointestinal, endocrine, and neurological diseases.

Nuclear Imaging Agents Market Outlook 2023-2033 ($ Million)

Buy the Full Report for More Insights into the Nuclear Imaging Agents Market Forecast, Download a Free Sample Report

The nuclear imaging agents market research report identifies quantitative market trends within diagnostic imaging therapeutic areas. The report offers regional quantitative and qualitative data highlighting the sales in major markets. The model also covers in detail the effects of COVID-19 on the nuclear imaging agents market for 2020 and beyond. Furthermore, the report provides nuclear imaging agents market share by company that will help in identifying untapped market opportunities.

Nuclear Imaging Agents Market Segments

The key segments of the nuclear imaging agents market are PET imaging agents and SPECT imaging agents. Gallium-67-Based SPECT imaging agents, Indium-Based SPECT imaging agents, Iodine-Based SPECT imaging agents, Lutetium-Based SPECT imaging agents, Technetium-Based SPECT imaging agents, and Thallium-Based SPECT imaging agents are the sub-categories of the leading segment. In 2023, the SPECT imaging agents segment accounted for the highest share of the market.

SPECT imaging agents are compounds that contain a small amount of material that emits radiation, called radiotracers. They are introduced into the body typically via injection, accumulate in particular areas, and can then be detected by SPECT molecular imaging cameras to help provide a detailed image of what is happening inside that area of the body.

Nuclear Imaging Agents Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment-Wise Insights into the Nuclear Imaging Agents Market, Download a Free Sample Report

Regional Analysis of Nuclear Imaging Agents Market

The key regions in the nuclear imaging agents market are Asia-Pacific, Europe, the Middle East, and Africa. North America and South and Central America are other leading regional markets. In 2023, the North American nuclear imaging agents market was the leading regional segment.

The US market drives the North American market. The market is expected to continue growing due to the increasing population with cancers, and cardiac and neurological diseases. Advancements in research and technology better access to healthcare facilities, availability of skilled professionals, better patient awareness, and improved health insurance policies are further driving the market ahead.

The US nuclear imaging agents market follows global and regional trends. In North America, the US leads the nuclear imaging market because of better research in the field of radiopharmaceuticals and technical advancements. KOLS indicated that the increasing aging population with cardiovascular diseases, access to good healthcare facilities, and better health insurance policies are the key factors that will drive the market ahead in the forecast period.

Nuclear Imaging Agents Market Analysis by Regions, 2023 (%)

Buy the Full Report for More Regional Insights in the Nuclear Imaging Agents Market, Download a Free Sample Report

Nuclear Imaging Agents Market – Competitive Landscape

In 2023, GE HealthCare Technologies Inc. nuclear imaging agents market share was the highest

The major players in the nuclear imaging agents market are:

• Cardinal Health Inc
• GE HealthCare Technologies Inc
• Novartis AG
• Bracco Imaging SpA
• Lantheus Holdings Inc

GE Healthcare Technologies Inc. leads the market by delivering innovative and sustainable solutions to improve the quality of life for their customers. Aging populations, increasing chronic and lifestyle-related diseases, accelerating demand for healthcare in emerging markets, and the increasing use of diagnostics and monitoring in patient care continue to fuel demand for GE’s offerings.

Nuclear Imaging Agents Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Company-Wise Insights into the Nuclear Imaging Agents Market, Download a Free Sample Report

Nuclear Imaging Agents Market Dynamics

• Drivers: The key factors positively impacting nuclear imaging agents market growth are the increasing population with cardiac and neurological ailments and betterment of healthcare facilities and the increasing number of diagnostic imaging centers. Furthermore, improvements in health insurance and reimbursement policies in developing countries and the unhealthy and sedentary lifestyle resulting in chronic ailments and cancer will also support the market growth.
• Barriers: Factors such as risk of radiation exposure, limited availability of skilled professionals, and the high cost of equipment may affect the demand for nuclear imaging agents. Additionally, the lack of technical advancement in remote areas will also negatively impact the nuclear imaging agents market growth.
• Future Outlook: Factors such as the rising aging population with cardiac and neurological ailments and increasing incidence of cancer among young and old populations will drive the nuclear imaging market in the forecast period. However, PET systems may not be replaced by SPECT systems even if they are cheap and technically advancing because PET systems give better-resolution images with less scatter and attenuation. The half-life of radiotracer is six hours which further increases the time of imaging. Unlike PET systems, SPECT systems produce qualitative images which can be uncertain.

Purchase the Complete Report for Additional Insights on the Nuclear Imaging Agents Market Dynamics, Get a Free Sample Report Here

Segments Covered in this Report

Nuclear Imaging Agents Segment Outlook ($ Million, 2015-2033)

• PET Imaging Agents
• SPECT Imaging Agents

Nuclear Imaging Agents Regional Outlook ($ Million, 2015-2033)

• Asia-Pacific
• Europe
• Middle East and Africa
• North America
• South and Central America

Key Inclusions of the market model are:

The nuclear imaging agents market research report includes an insightful review of the key industry trends.

• The nuclear imaging agents market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
• The report also includes market-level data on units, average selling prices, and market values.

Regional, Country, and Global Nuclear Imaging Agents Market Insights:

• The nuclear imaging agents market share report offers qualitative insights on global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• Nuclear imaging agents market SWOT analysis.
• The report provides trends and Nuclear Imaging Agents’ market competitive dynamics.

Buy the Full Report for More Insights on the Nuclear Imaging Agents Market Share, Download a Free Sample Report

Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. In addition, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.

Companies Covered: Cardinal Health Inc., GE HealthCare Technologies Inc., Advanced Accelerator Applications SA, Bracco Diagnostics Inc., Lantheus Medical Imaging Inc., and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

• Extensive coverage of the nuclear imaging agents market under development.
• An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
• Reviews of major players involved in the development of the nuclear imaging agents market and lists all their pipeline projects.
• Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
• Key clinical trial data of ongoing clinical trials specific to pipeline products.
• Recent developments in the segment/industry.

Reasons to Buy

• Understand the COVID-19 impact on nuclear imaging agents.
• Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving nuclear imaging agents.
• Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.
• Formulate effective sales and marketing strategies with a detailed evaluation of nuclear imaging agents’ market share by company. Identify strong competitors and create winning strategies to stand out in the global nuclear imaging agents market.
• Track regional nuclear imaging agents market sales as well as country-specific transactions from 2015-2033.
• Organize your sales and marketing efforts by identifying the global nuclear imaging agents market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.